Detalles de la búsqueda
1.
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.
iScience;
26(12): 108500, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089581
2.
Paediatric acute hepatitis of unknown aetiology: a national investigation and adenoviraemia case-control study in the UK.
Lancet Child Adolesc Health;
7(11): 786-796, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37774733
3.
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.
J Infect;
87(4): 315-327, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37579793
4.
Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study.
Pediatr Infect Dis J;
42(6): 496-502, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36916856
5.
Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2.
Nat Microbiol;
7(8): 1180-1188, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35836002
6.
Effectiveness of oral aciclovir in preventing maternal chickenpox: A comparison with VZIG.
J Infect;
85(2): 147-151, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35659543
7.
Mind your Ps: A probabilistic model to aid the interpretation of molecular epidemiology data.
EBioMedicine;
79: 103989, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35398788
8.
Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England.
EClinicalMedicine;
45: 101319, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35233517
9.
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England.
J Infect;
84(5): 692-700, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35131335
10.
Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England.
Nat Commun;
13(1): 733, 2022 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35110555
11.
Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England.
PLoS One;
17(2): e0262515, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35171942
12.
SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements.
Microbiol Spectr;
10(1): e0078621, 2022 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34985331
13.
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups.
J Infect;
84(5): 675-683, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990709
14.
Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021.
Euro Surveill;
27(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34991777
15.
Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination.
J Infect;
84(3): 418-467, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861351
16.
VITT and Second Doses of Covid-19 Vaccine.
N Engl J Med;
386(1): 95, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936738
17.
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
Nat Immunol;
23(1): 40-49, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937928
18.
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England.
Nat Commun;
12(1): 7217, 2021 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34893611
19.
Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England.
EClinicalMedicine;
41: 101150, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608455
20.
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England.
J Infect;
83(5): 573-580, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34400220